H. pylori Infection and Gastric Cancer Risk - podcast episode cover

H. pylori Infection and Gastric Cancer Risk

Jul 11, 202312 minEp. 35
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

First, we'll discuss a Korean trial that looked at the role of H. pylori infection and gastric cancer risk. Next, we'll turn to a modeling study that examined HPV vaccination and cervical cancer incidence in low-income and lower–middle-income countries. Last this week, we'll look at data presented at the ASCO-SITC Clinical Immuno-Oncology Symposium on reducing the risk for immune checkpoint inhibitor–associated colitis.

Coverage of stories discussed this week on ascopost.com:

Does Treating Individuals for H pylori Infection Reduce Gastric Cancer Risk in Those With a Family History of the Disease?

Modeling the Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination in Low-Income and Lower-Middle–Income Countries

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> First, we'll discuss a Korean trial that looked at the role of H. pylori infection and gastric cancer risk. Next, we'll turn to a modeling study that examined HPV vaccination and cervical cancer incidence in low-income and lower–middle-income countries. Last this week, we'll look at data presented at the ASCO-SITC Clinical Immuno-Oncology Symposium on reducing the risk for immune checkpoint inhibitor–associated colitis.

First, we'll discuss a Korean trial that looked at the role of H. pylori infection and gastric cancer risk. Next, we'll turn to a modeling study that examined HPV vaccination and cervical cancer incidence in low-income and lower–middle-income countries. Last this week, we'll look at data presented at the ASCO-SITC Clinical Immuno-Oncology Symposium on reducing the risk for immune checkpoint inhibitor–associated colitis.

Coverage of stories discussed this week on ascopost.com:

Does Treating Individuals for H pylori Infection Reduce Gastric Cancer Risk in Those With a Family History of the Disease?

Modeling the Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination in Low-Income and Lower-Middle–Income Countries

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Coverage of stories discussed this week on ascopost.com:

First, we'll discuss a Korean trial that looked at the role of H. pylori infection and gastric cancer risk. Next, we'll turn to a modeling study that examined HPV vaccination and cervical cancer incidence in low-income and lower–middle-income countries. Last this week, we'll look at data presented at the ASCO-SITC Clinical Immuno-Oncology Symposium on reducing the risk for immune checkpoint inhibitor–associated colitis.

Coverage of stories discussed this week on ascopost.com:

Does Treating Individuals for H pylori Infection Reduce Gastric Cancer Risk in Those With a Family History of the Disease?

Modeling the Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination in Low-Income and Lower-Middle–Income Countries

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Does Treating Individuals for H pylori Infection Reduce Gastric Cancer Risk in Those With a Family History of the Disease?

First, we'll discuss a Korean trial that looked at the role of H. pylori infection and gastric cancer risk. Next, we'll turn to a modeling study that examined HPV vaccination and cervical cancer incidence in low-income and lower–middle-income countries. Last this week, we'll look at data presented at the ASCO-SITC Clinical Immuno-Oncology Symposium on reducing the risk for immune checkpoint inhibitor–associated colitis.

Coverage of stories discussed this week on ascopost.com:

Does Treating Individuals for H pylori Infection Reduce Gastric Cancer Risk in Those With a Family History of the Disease?

Modeling the Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination in Low-Income and Lower-Middle–Income Countries

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Modeling the Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination in Low-Income and Lower-Middle–Income Countries

For the best experience, listen in Metacast app for iOS or Android